WLKP
Westlake Chemical Partners LP

Market cap $754.29M
Enterprise value $1.2109B
Employees N/A
Revenue $1.16B
EBITDA $466M
Income $42.8M
EPS 1.58
P/E 14.82
Forward P/E 11.41
EV/EBITDA 2.60
PEG 1.19
Earnings date 2018-04-30
Volume 33.1k / 87.8k
Relative vol. 0.38 ×
Sales Q/Q 0.97%
Sales Y/Y -22.23%
Est. EPS Q/Q 28.57%
Beta 1.00
Mean Recomm. 2.10
IPO year 2014
Country United States
RSI 40.30
Range $23.06 – $23.55
52 weeks $21.10 – $26.20
SMA 50 $24 +2.13%
SMA 200 $23 -0.48%
1 year target $27 +13.25%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Tuesday, 6 February 2018
+0.00%
businesswire
Westlake Chemical Partners Announce Fourth Quarter and Full Year Earnings for 2017 Conference Call
Friday, 2 February 2018
+1.05%
simplywall.st
Is Westlake Chemical Partners LP’s PE Ratio A Signal To Buy For Investors?
Tuesday, 30 January 2018
-0.21%
marketrealist
CVR Partners: Top MLP Loser in the Week Ending January 26
Monday, 29 January 2018
+0.00%
businesswire
Westlake Chemical Partners LP Announces Fourth Quarter Distribution
Monday, 22 January 2018
+0.82%
globenewswire
Market Trends Toward New Normal in Vi, Comcast, Great Plains Energy, RCI Hospitality, City Holding, and Westlake Chemical Partners LP — Emerging Consolidated Expectations, Analyst Ratings
Monday, 15 January 2018
zacks
Westlake Chemical Up 89% in a Year: What's Behind the Rally?
Monday, 8 January 2018
-0.40%
marketrealist
MLP Rating Updates for Week Ended January 5
Tuesday, 2 January 2018
-0.20%
zacks
Westlake Chemical Hits New 52-Week High: What's Driving It?
Wednesday, 27 December 2017
+0.85%
zacks
Westlake Chemical Up 62% in 6 Months: Here's Why
Tuesday, 26 December 2017
-0.42%
marketrealist
Westlake Announces Optional Redemption of Senior Notes
zacks
Top Ranked Momentum Stocks to Buy for December 26th
Thursday, 21 December 2017
-0.21%
simplywall.st
Where Westlake Chemical Partners LP Stands In Terms Of Earnings Growth Against Its Industry
simplywall.st
Did Westlake Chemical Corporation Create Value For Shareholders?
marketrealist
What’s Eastman Chemical’s Short Interest?
zacks
Marrone Bio Inks Regalia Maxx Distribution Deal With Disagro
Tuesday, 19 December 2017
+0.85%
investors
Westlake Chemical Earns Membership In 95-Plus Composite Rating Club
Thursday, 14 December 2017
-0.64%
zacks
The Zacks Analyst Blog Highlights: Kronos Worldwide, Westlake Chemical, Kraton, Albemarle and Celanese
Wednesday, 13 December 2017
+0.00%
zacks
U.S. Chemical Industry Set to Ride High: 5 Stocks for 2018
Tuesday, 12 December 2017
+0.21%
zacks
Cleveland-Cliffs Closes Acquisition of Real Estate Interests
zacks
Westlake Chemical Stock Up 80% YTD: What's Driving It?
Thursday, 7 December 2017
+0.67%
marketrealist
Westlake Chemical’s Valuation: Still Better Than Peers
zacks
Can Westlake Chemical Run Higher on Strong Earnings Estimate Revisions?
marketrealist
Why the Consensus Target Price for Westlake Chemical Is Changing
Wednesday, 6 December 2017
+1.35%
marketrealist
Why Westlake Chemical’s Dividend Yield Continues to Slide
marketrealist
Westlake Chemical Is Set to Pay Its 4Q17 Dividend
marketrealist
Can Westlake Chemical Continue to Create Investor Wealth?
Tuesday, 5 December 2017
+0.00%
businesswire
Westlake Chemical Partners LP Increases Capacity of Revolving Credit Facility
zacks
How Westlake Chemical Stock Stands Out in a Strong Industry
Monday, 4 December 2017
-1.56%
zacks
CF Industries Subsidiary Redeems Senior Notes Due 2018
zacks
Barrick Invests in Reunion Gold, Acquires 15% Stake
Friday, 1 December 2017
+1.36%
simplywall.st
How Westlake Chemical Partners LP Delivered A Better ROE Than Its Industry
zacks
Westlake Chemical Closes Offering of Senior Notes
Thursday, 30 November 2017
+0.00%
zacks
Celanese Set to Raise Acetaldehyde Price in Europe
Tuesday, 28 November 2017
+0.00%
zacks
5 Reasons to Add Westlake Chemical to Your Portfolio Now
Monday, 27 November 2017
-0.23%
marketrealist
Westlake Chemical Prices Its 2017 Revenue Refunding Bonds
Wednesday, 22 November 2017
+1.17%
zacks
3 Reasons Why Westlake Chemical is a Great Momentum Stock
zacks
Westlake Chemical Declares Pricing of Tax-Exempt Bonds
Tuesday, 21 November 2017
-0.81%
zacks
Westlake Chemical Up 32% in 3 Months: What's Driving It?
Friday, 17 November 2017
+0.70%
nasdaq
Tortoise Capital Advisors, Llc Buys Andeavor Logistics LP, ONEOK Inc, Shell ...
Monday, 13 November 2017
-0.69%
nasdaq
Tortoise Capital Advisors, Llc Buys ONEOK Inc, Apache Corp, Shell Midstream ...
Friday, 10 November 2017
-1.56%
zacks
Zacks Industry Outlook Highlights: DowDuPont, Albemarle, Monsanto, Westlake Chemical and Kraton
Wednesday, 8 November 2017
-0.22%
zacks
Westlake Chemical Corporation Looks Good: Stock Adds 6.5% in Session
zacks
Westlake Chemical Q3 Earnings Top, Revenues Trail
Tuesday, 7 November 2017
-1.09%
seekingalpha
Westlake Chemical Partners' CEO Albert Chao on Q3 2017 Results ...
accesswire
Westlake Chemical Partners LP to Host Earnings Call
zacks
Westlake Chemical Q3 Earnings Top Estimates, Sales Miss
ap
Westlake tops 3Q profit forecasts
ap
Westlake Chemical Partners posts 3Q profit
reuters
Westlake Chemical Partners reports Q3 earnings per share $0.47
businesswire
Westlake Chemical Partners LP Announces Third Quarter 2017 Earnings
Monday, 6 November 2017
-0.88%
zacks
Is a Surprise Coming for Westlake Chemical This Earnings Season?
Friday, 3 November 2017
-0.67%
zacks
Westlake Chemical Q3 Earnings: A Beat in the Cards?
Friday, 3 November 2017
-0.67%
zacks
CVR Partners Q3 Earnings Trail Estimates, Sales Decline
Wednesday, 1 November 2017
+0.90%
businesswire
Westlake Chemical Partners LP Announces Third Quarter Distribution
Monday, 30 October 2017
+1.35%
nasdaq
Andeavor Logistics Completes Acquisition of Western Refining Logistics and IDR ...
Tuesday, 17 October 2017
+0.00%
businesswire
Westlake Chemical Partners Announce Third Quarter 2017 Conference Call
Monday, 16 October 2017
+2.24%
markit
See what the IHS Markit Score report has to say about Westlake Chemical Corp.
Friday, 13 October 2017
-1.11%
zacks
Here's Why Westlake Chemical is a Good Investment Pick
Thursday, 12 October 2017
-0.22%
zacks
Can Westlake Chemical Prove to be Suitable Value Pick?
Monday, 2 October 2017
-1.97%
simplywall.st
At $22.7, Is Westlake Chemical Partners LP A Buy?
simplywall.st
At $83.09, Is It Time To Buy Westlake Chemical Corporation ?
Sunday, 1 October 2017
seekingalpha
Anti-CliMax Weight
Wednesday, 27 September 2017
+0.69%
seekingalpha
Westlake Chemical Partners - Equity Issuance Dip And Asset Drop-Down Create 65 ...
Tuesday, 26 September 2017
+0.66%
reuters
Westlake Chemical Partners prices offering of common units
reuters
Westlake Chemical Partners says offering 4.5 mln common units
businesswire
Westlake Chemical Partners LP Acquires Additional Interest in Westlake Chemical OpCo
reuters
Westlake Chemical Partners LP acquires additional interest in Westlake Chemical OpCo
Monday, 4 September 2017
zacks
Westlake Chemical Up 10% in a Month: What's Driving It?
Saturday, 2 September 2017
fool
These 3 Stocks Just Raised Their Dividends
Friday, 1 September 2017
+1.05%
marketrealist
Analyzing Westlake Chemical’s Stock Performance
Monday, 28 August 2017
-0.42%
bloomberg
Harvey Disrupts More Than One Third of US Chemical Production
Thursday, 10 August 2017
-0.62%
nasdaq
Westlake Chemical Partners LP Ex-Dividend Date Scheduled for August 11 ...
Sunday, 6 August 2017
seekingalpha
Westlake Chemical Partners' CEO Albert Chao on Q2 2017 Results ...
Thursday, 3 August 2017
+1.01%
seekingalpha
Westlake Chemical Q2 2017 Results - Earnings Call Transcript
reuters
Westlake Chemical Partners Q2 earnings per share $0.36
Tuesday, 30 May 2017
-1.83%
marketwatch
You might profit handsomely for decades with this bet on natural gas
Thursday, 11 May 2017
+1.82%
nasdaq
Tiedemann Wealth Management, Llc Buys iShares Core S&P Total US ...
Tuesday, 2 May 2017
-0.62%
seekingalpha
Westlake Chemical Partners' CEO Albert Chao on Q1 2017 Results ...
Sunday, 30 April 2017
seekingalpha
Westlake Chemical Partners: The Cyclical Nature Of The Chemical Industry
Friday, 28 April 2017
-0.59%
seekingalpha
A Distribution Growth Juggernaut With 50% Upside
Friday, 10 March 2017
-1.37%
reuters
Westlake Chemical Partners files for offering of common units
Tuesday, 21 February 2017
+0.61%
seekingalpha
Westlake Chemical Partners' CEO Albert Chao on Q4 2016 Results ...
reuters
Westlake Chemical Partners posts Q4 earnings $0.39/shr
Thursday, 2 February 2017
-0.58%
seekingalpha
Westlake Partners Is Great Growth And Value Investment
Friday, 27 January 2017
+2.46%
reuters
Westlake Chemical Partners declares distribution of $0.3450 per unit
Thursday, 19 January 2017
+2.17%
reuters
Westlake Chemical provides statement on final regulations
Thursday, 24 November 2016
seekingalpha
Backtesting 101, Part 1: The Misunderstood Investing Tool
Tuesday, 8 November 2016
+0.50%
reuters
Westlake Chemical Partners LP reports Q3 net income attributable to partnership of $0.32 per LP unit
Saturday, 30 July 2016
seekingalpha
Westlake Chemical Partners' CEO Albert Chao on Q2 2016 Results ...
Thursday, 28 July 2016
-4.69%
reuters
Westlake Chemical Partners Q2 net income $0.34 per limited partner unit
reuters
General Partner declares distribution of $0.3259 per unit
Thursday, 5 May 2016
+2.55%
nasdaq
Westlake Chemical Partners LP Ex-Dividend Date Scheduled for May 06, 2016
Wednesday, 20 January 2016
+0.87%
fool
Will 2016 Be Ashland Inc.'s Best Year Yet?
Monday, 4 January 2016
-2.25%
seekingalpha
Compelling Valuation, High Distribution Yield: Consider Westlake Chemical ...
Wednesday, 28 October 2015
+0.23%
reuters
Westlake Chemical Partners LP announces third quarter distribution
Friday, 16 October 2015
+0.22%
seekingalpha
Westlake Chemical Partners - Not Your Usual MLP With A 6% Yield
Wednesday, 29 July 2015
-0.14%
reuters
Westlake Chemical Partners GP LLC announces second quarter distribution
Tuesday, 23 June 2015
+1.13%
seekingalpha
Westlake Chemical Partners Takes A Blow From The IRS - There's An Opportunity Here
Friday, 8 May 2015
-3.29%
zacks
3 Reasons Why Westlake Chemical Partners is a Great Value Stock
Friday, 1 August 2014
-3.59%
marketwatch
24.30
Wednesday, 30 July 2014
+1.65%
seekingalpha
IPO Preview: Westlake Chemical Partners LP
Saturday, 14 December 2013
marketwatch
26.13
Wednesday, 16 November 2011
marketwatch
0.73
Wednesday, 19 January 2011
marketwatch
103.74
Thursday, 14 October 2010
marketwatch
50.35
Date
#
Company
Insider Title
Trans.
Transaction
Shares Price per share Total price Shares after Source
2017-11-22 Albert Chao
President & CEO
President & CEO Buy 2,000 $21.49 $42,980
2017-11-22
47,000
2017-08-20 Max L Lukens
Director
Director Option exercise 2,202 $0.00 $0
2017-08-20
127,202
2017-08-07 Lawrence E. Teel
SVP, Olefins
SVP, Olefins Buy 300 $25.15 $7,545
2017-08-07
2,800
2017-03-09 David Lumpkins
Director
Director Buy 2,500 $25.42 $63,550
2017-03-09
5,000
2017-03-07 David Lumpkins
Director
Director Buy 2,500 $25.63 $64,075
2017-03-07
2,500
2016-11-30 Angela A Minas
Director
Director Buy 5,000 $21.00 $105,000
2016-11-30
5,000
2014-08-04 James Chao
Director
Director Buy 1,526,115 $1.42 $2,167,083
2014-08-04
45,000
2014-08-04 Albert Chao
President & CEO
President & CEO Buy 1,526,115 $1.42 $2,167,083
2014-08-04
45,000
2014-08-04 Mark Steven Bender
Sr VP, CFO
Sr VP, CFO Buy 10,000 $24.00 $240,000
2014-08-04
10,000
2014-08-04 Gary Kramer Adams
Director
Director Buy 5,000 $24.00 $120,000
2014-08-04
5,000
2014-08-04 Lawrence E. Teel
SVP, Olefins
SVP, Olefins Buy 2,500 $24.00 $60,000
2014-08-04
2,500
2014-08-04 George J Mangieri
VP & Chief Accounting Officer
VP & Chief Accounting Officer Buy 5,000 $24.00 $120,000
2014-08-04
5,000
2014-08-04 Max L Lukens
Director
Director Buy 125,000 $24.00 $3,000,000
2014-08-04
125,000
2014-08-04 David R Hansen
Sr VP Adminstration
Sr VP Adminstration Buy 10,000 $24.00 $240,000
2014-08-04
10,000
2014-08-04 L. Benjamin Ederington
VP, General Counsel
VP, General Counsel Buy 10,000 $24.00 $240,000
2014-08-04
10,000

Notable SEC filings of Westlake Chemical Partners LP

Date Contents
Source
2017-11-07 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2017-10-03 8-K Completion of Acquisition or Disposition of Assets; Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; Financial Statements and Exhibits
2017-09-28 8-K Other Events; Financial Statements and Exhibits
2017-09-26 8-K Regulation FD Disclosure; Other Events; Financial Statements and Exhibits
2017-08-03 10-Q Quarterly report
2017-08-03 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2017-05-03 10-Q Quarterly report
2017-05-02 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2017-03-07 10-K Yearly report
2017-02-21 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2017-01-24 8-K Regulation FD Disclosure; Financial Statements and Exhibits
2017-01-23 8-K Regulation FD Disclosure; Financial Statements and Exhibits
2017-01-20 8-K Regulation FD Disclosure; Financial Statements and Exhibits
2016-11-09 10-Q Quarterly report
2016-11-08 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2016-10-11 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure; Financial Statements and Exhibits
2016-08-09 10-Q Quarterly report
2016-07-28 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2016-05-04 10-Q Quarterly report
2016-05-03 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2016-03-08 10-K Yearly report
2016-02-23 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2015-11-04 10-Q Quarterly report
2015-11-03 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
2015-08-05 10-Q Quarterly report
2015-08-04 8-K Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits
Equal-Weight Barclays 19 December 2017
Buy Citigroup 4 December 2017

Westlake Chemical Partners LP executives

Insider Title Age Since Compensation
Albert Chao (67)
President, Chief Executive Officer, Director of Westlake Chemical Partners GP LLC, since 2014
President, Chief Executive Officer, Director of Westlake Chemical Partners GP LLC, 67 2014 $985,000
Mark Bender (60)
Chief Financial Officer, Senior Vice President, Director of Westlake Chemical Partners GP LLC since 2014
Chief Financial Officer, Senior Vice President, Director of Westlake Chemical Partners GP LLC 60 2014 $525,000
Angela Minas (52)
Independent Director of Westlake Chemical Partners GP LLC since 2016
Independent Director of Westlake Chemical Partners GP LLC 52 2016
David Lumpkins (62)
Independent Director of Westlake Chemical Partners GP LLC since 2015
Independent Director of Westlake Chemical Partners GP LLC 62 2015
Max Lukens (68)
Independent Director since 2014
Independent Director 68 2014
L. Benjamin Ederington (46)
Vice President, General Counsel, Secretary, Director of Westlake Chemical Partners LP since 2014
Vice President, General Counsel, Secretary, Director of Westlake Chemical Partners LP 46 2014
George Mangieri (66)
Chief Accounting Officer, Vice President of Westlake Chemical Partners GP LLC since 2014
Chief Accounting Officer, Vice President of Westlake Chemical Partners GP LLC 66 2014
Lawrence Teel (58)
Senior Vice President - Olefins since 2014
Senior Vice President - Olefins 58 2014
James Chao (69)
Chairman of the Board of Westlake Chemical Partners GP LLC, since 2014
Chairman of the Board of Westlake Chemical Partners GP LLC, 69 2014
Westlake Chemical Partners LP logo

Westlake Chemical Partners LP operates, acquires, and develops ethylene production facilities and related assets in the United States. The company operates ethylene production facilities, which primarily convert ethane into ethylene. It also sells ethylene co-products, including propylene, crude butadiene, pyrolysis gasoline, and hydrogen directly to third parties on a spot or contract basis. Westlake Chemical Partners GP LLC serves as the general partner of the company. The company was founded in 2014 and is headquartered in Houston, Texas.

  • Westlake Chemical Partners LP, 2801 Post Oak Boulevard, Houston 77056, United States
  • wlkpartners.com
  • 713-585-2900

Quarterly EPS estimates

Profit margin

Debt to assets

Cash flow

Balance sheet

(in millions) 2017Q3 2017Q2 2017Q1 2016Q4
Current assets
Cash $17.249 $104.939 $122.974 $88.9
Short term investments
Net receivables $196.065 $94.087 $101.928 $139.062
Inventory $3.881 $4.558 $4.776 $3.934
Other current assets $0.413 $0.045 $0.154 $0.269
Total current assets $217.608 $203.629 $229.832 $232.165
Long term investments
Property, plant & equipment $1,206.246 $1,220.393 $1,223.239 $1,222.238
Goodwill $5.814 $5.814 $5.814 $5.814
Intangible assets
Other assets
Deferred long term asset charges $88.03 $92.741 $97.915 $95.011
Total assets $1,517.698 $1,522.577 $1,556.8 $1,555.228
Current liabilities
Accounts payable $44.92 $36.39 $46.645 $37.777
Short long term debt
Other current liabilities
Total current liabilities $44.92 $36.39 $46.645 $37.777
Long term debt $477.121 $588.28 $600.206 $594.629
Other liabilities $0.079 $0.168 $0.136 $0.123
Deferred long term liabilities $2.099 $1.936 $1.828 $1.736
Minority interest $776.618 $792.85 $805.126 $818.479
Total liabilities $1,300.837 $1,419.624 $1,453.941 $1,452.744
Stockholders' equity
Stock option warrants
Common stock
Retained earnings
Treasury stock
Capital surplus
Other stockholder equity $216.861 $102.953 $102.859 $102.484
Total stockholder equity
Net tangible assets -$5.814 -$5.814 -$5.814 -$5.814
(in millions) 2016 2015 2014
Current assets
Cash $88.9 $169.559 $133.75
Short term investments
Net receivables $139.062 $51.582 $56.049
Inventory $3.934 $3.879 $6.634
Other current assets $0.269 $0.267 $0.212
Total current assets $232.165 $225.287 $196.645
Long term investments
Property, plant & equipment $1,222.238 $1,020.469 $842.057
Goodwill $5.814 $5.814 $5.814
Intangible assets
Other assets
Deferred long term asset charges $95.011 $38.779 $51.919
Total assets $1,555.228 $1,290.349 $1,096.435
Current liabilities
Accounts payable $37.777 $57.694 $31.984
Short long term debt
Other current liabilities
Total current liabilities $37.777 $57.694 $31.984
Long term debt $594.629 $384.006 $227.638
Other liabilities $0.123 $0.09 $0.015
Deferred long term liabilities $1.736 $1.392 $1.848
Minority interest $818.479 $750.606 $747.426
Total liabilities $1,452.744 $1,193.788 $1,008.911
Stockholders' equity
Stock option warrants
Common stock
Retained earnings
Treasury stock
Capital surplus
Other stockholder equity $102.484 $96.561 $87.524
Total stockholder equity
Net tangible assets -$5.814 -$5.814 -$5.814

Income statement

(in millions) 2017Q3 2017Q2 2017Q1 2016Q4
Revenue
Total revenue $296.775 $290.113 $277.448 $293.937
Cost of revenue $201.372 $190.542 $179.487 $188.202
Gross profit $95.403 $99.571 $97.961 $105.735
Operating expenses
Research & development
Selling, general & administrative $6.805 $6.886 $7.828 $7.154
Non-recurring
Other operating expenses
Total operating expenses
Operating income $88.598 $92.685 $90.133 $98.581
Income from continuing operations
Net other income $0.162 $0.024 $1.658 $0.371
EBIT $88.76 $92.709 $91.791 $98.952
Interest expense $6.19 $5.942 $5.46 $5.226
Income before tax $82.57 $86.767 $86.331 $93.726
Income tax expense $0.325 $0.297 $0.303 $0.145
Minority interest $776.618 $792.85 $805.126 $818.479
Net income from continuing ops $13.385 $9.975 $9.764 $10.851
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
EBITDA $13.385 $9.975 $9.764 $10.851
Income (for common shares) $13.385 $9.975 $9.764 $10.851
(in millions) 2016 2015 2014
Revenue
Total revenue $986.736 $1,007.221 $1,749.7
Cost of revenue $595.405 $624.339 $1,003.888
Gross profit $391.331 $382.882 $745.812
Operating expenses
Research & development
Selling, general & administrative $24.887 $23.55 $29.256
Non-recurring
Other operating expenses
Total operating expenses
Operating income $366.444 $359.332 $716.556
Income from continuing operations
Net other income $0.601 $0.16 $3.151
EBIT $367.045 $359.492 $719.707
Interest expense $12.607 $4.967 $10.499
Income before tax $354.438 $354.525 $709.208
Income tax expense $1.035 $0.672 $199.388
Minority interest $818.479 $750.606 $747.426
Net income from continuing ops $40.94 $39.831 $374.911
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
EBITDA $40.94 $39.831 $374.911
Income (for common shares) $40.94 $39.831 $13.577

Cash flow

(in millions) 2017Q3 2017Q2 2017Q1 2016Q4
Net income $13.385 $9.975 $9.764 $10.851
Operating activities
Depreciation $29.053 $27.299 $30.15 $30.738
Net income adjustments $2.397 -$0.489 -$0.615 $0.734
Change in accounts receivable $17.587 $15.171 $31.257 -$0.262
Changes in liabilities $9.066 -$15.633 $12.611 -$12.241
Changes in inventory $0.677 $0.218 -$0.842 -$0.506
Changes in other operating activities -$1.395 $0.172 -$9.511 -$1.688
Total cash flow from operations $139.63 $113.208 $149.078 $110.356
Investing activities
Capital expenditures -$12.611 -$20.828 -$23.168 -$30.991
Investments -$119 -$119 -$119 -$119
Other cash flows from investing $0.002 $0.117 $1.682 $1.682
Total cash flows from investing -$131.609 -$20.711 -$21.486 -$30.991
Financing activities
Dividends paid -$95.291 -$98.606 -$99.095 -$65.017
Sale and purchase of stock $110.739 $110.739 $110.739 $110.739
Net borrowings -$111.159 -$11.926 $5.577 -$0.454
Other cash flows from financing
Total cash flows from financing -$95.711 -$110.532 -$93.518 -$65.471
Effect of exchange rate
Change in cash and equivalents -$87.69 -$18.035 $34.074 $13.894
(in millions) 2016 2015 2014
Net income $40.94 $39.831 $374.911
Operating activities
Depreciation $98.21 $81.21 $77.611
Net income adjustments $3.759 $1.526 $11.29
Change in accounts receivable -$91.294 $13.588 -$42.61
Changes in liabilities $1.616 $3.153 $15.251
Changes in inventory -$0.055 $2.755 $24.686
Changes in other operating activities -$77.913 -$3.543 $7.964
Total cash flow from operations $287.726 $452.542 $604.012
Investing activities
Capital expenditures -$299.638 -$231.185 -$202.823
Investments -$0.133
Other cash flows from investing $0.157 $0.157 $0.157
Total cash flows from investing -$299.481 -$231.185 -$202.956
Financing activities
Dividends paid -$279.527 -$341.916 -$504.367
Sale and purchase of stock $134.359
Net borrowings $210.623 $156.368 $102.702
Other cash flows from financing
Total cash flows from financing -$68.904 -$185.548 -$267.306
Effect of exchange rate
Change in cash and equivalents -$80.659 $35.809 $133.75
Messenger